IL10, interleukin 10, 3586

N. diseases: 1679; N. variants: 21
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Zoonotic form of cutaneous leishmaniasis
0.010 AlteredExpression disease BEFREE MCP-1 and IL-10 were expressed at comparable levels in ZCL and SCL lesions. 30810524 2019
CUI: C0043407
Disease: Yersinia infections
Yersinia infections
0.020 Biomarker group BEFREE The relevance of LcrV-mediated immunosuppression for the pathogenicity of yersiniae became evident by experimental infection of mice; in contrast to wild-type mice, IL-10-/- mice were highly resistant against Yersinia infection, as shown by lower bacterial load in spleen and liver, absent abscess formation in these organs, and survival. 11801671 2002
CUI: C0043407
Disease: Yersinia infections
Yersinia infections
0.020 AlteredExpression group BEFREE Tissue levels of IL-10, as well as the inflammatory cytokines TNF-alpha, IL-6, and gamma interferon and the chemokine macrophage chemotactic protein 1, are similar in TLR2(+/+) and TLR2(-/-) mice during enteropathogenic Yersinia infection. 17420232 2007
CUI: C0043395
Disease: Yellow Fever
Yellow Fever
0.010 Biomarker disease BEFREE For this purpose, memory status of circulating T-cells (Naïve/early-effector/Central-Memory/Effector-Memory) and B-cells (Naïve/non-Classical-Memory/Classical-Memory) along with the cytokine profile (IFN/TNF/IL-5/IL-10) were monitored before-NV(day0) and at distinct time-points after 17DD-YF primary vaccination-PV(day30-45); PV(year1-9) and PV(year10-11). 29879134 2018
CUI: C0238052
Disease: Xanthomatosis, Cerebrotendinous
Xanthomatosis, Cerebrotendinous
0.010 AlteredExpression disease BEFREE However, imipenem combined with low-dose CTX significantly reduced IL-6 and IL-10 expression and significantly increased occludin expression compared with imipenem alone (P<0.05). 30186419 2018
X-Linked Lymphoproliferative Disorder
0.020 Biomarker disease BEFREE Thus, insufficient IL-10 production may contribute to hypogammaglobulinemia in XLP. 15761493 2005
X-Linked Lymphoproliferative Disorder
0.020 Biomarker disease BEFREE Intracellular IL-10, IL-21 and IL-4 reached higher values in XLP than N after 8 days. 21996454 2011
CUI: C0221026
Disease: X-linked agammaglobulinemia
X-linked agammaglobulinemia
0.010 AlteredExpression disease BEFREE We found that XLA-DC normally differentiate from monocyte precursors and mature in response to lipopolysaccharide (LPS) as assessed by de novo expression of CD83, up-regulation of MHC class II, B7.1 and B7.2 molecules as well as interleukin (IL)-12 and IL-10 production. 12823285 2003
CUI: C0043144
Disease: Wheezing
Wheezing
0.090 AlteredExpression phenotype BEFREE Furthermore, wheezing children with MPP had a significantly higher level of IL-10 than children with MPP without wheezing (43.75±26.644 vs. 27.50±10.211 pg/ml, p=0.027). 28057814 2017
CUI: C0043144
Disease: Wheezing
Wheezing
0.090 GeneticVariation phenotype BEFREE We aimed to determine whether IL10 polymorphisms are associated with helminth infection and the risk of wheeze and allergy. 23273955 2013
CUI: C0043144
Disease: Wheezing
Wheezing
0.090 GeneticVariation phenotype BEFREE Regarding the clinical outcomes, reduced LPS-induced IL-10 responses at birth were associated with recurrent wheeze. 28089873 2017
CUI: C0043144
Disease: Wheezing
Wheezing
0.090 Biomarker phenotype BEFREE Interleukin-10 (IL-10) has been associated with wheezing and asthma in children and the genetic variation of the IL-10 cytokine production may be linked to post-bronchiolitis lung function. 26473365 2015
CUI: C0043144
Disease: Wheezing
Wheezing
0.090 Biomarker phenotype BEFREE IL10 family member genes IL19 and IL20 are associated with recurrent wheeze after respiratory syncytial virus bronchiolitis. 21814157 2011
CUI: C0043144
Disease: Wheezing
Wheezing
0.090 GeneticVariation phenotype BEFREE IL10 polymorphisms influence neonatal immune responses, atopic dermatitis, and wheeze at age 3 years. 23021880 2013
CUI: C0043144
Disease: Wheezing
Wheezing
0.090 Biomarker phenotype BEFREE We previously showed that airflow limitation during RSV LRTI as well as convalescent monocyte IL-10 production are associated with early wheezing. 17313976 2007
CUI: C0043144
Disease: Wheezing
Wheezing
0.090 GeneticVariation phenotype BEFREE IL-10 polymorphisms at rs1800871, rs1800872, rs1800890, and rs1800896 seem to be associated with elevated allergies and/or recurrent wheezing risk in later childhood, after early-life bronchiolitis.Pediatr Pulmonol.2017;52:14-20. 27228545 2017
CUI: C0043144
Disease: Wheezing
Wheezing
0.090 Biomarker phenotype BEFREE Wheeze was inversely associated with SWA-specific IFN-γ (P < .001) and IL-10 (P = .058), and SEA-specific IL-5 (P = .004). 29171863 2018
CUI: C1096184
Disease: West Nile viral infection
West Nile viral infection
0.010 Biomarker disease BEFREE Consistent with an etiologic role of IL-10 in WNV pathogenesis, we find that WNV infection is markedly diminished in IL-10 deficient (IL-10(-/-)) mice, and pharmacologic blockade of IL-10 signaling by IL-10 neutralizing antibody increases survival of WNV-infected mice. 19816558 2009
CUI: C0043124
Disease: West Nile Fever
West Nile Fever
0.010 Biomarker disease BEFREE Moreover, CD4(+) T cells produce copious amounts of IL-10, and may be an important cellular source of IL-10 during WNV infection in vivo. 19816558 2009
CUI: C1262477
Disease: Weight decreased
Weight decreased
0.400 Therapeutic phenotype CTD_human Effects of interleukin-4 or interleukin-10 gene therapy on trinitrobenzenesulfonic acid-induced murine colitis. 24314293 2013
CUI: C1262477
Disease: Weight decreased
Weight decreased
0.400 Biomarker phenotype CTD_human Effects of interleukin-4 or interleukin-10 gene therapy on trinitrobenzenesulfonic acid-induced murine colitis. 24314293 2013
CUI: C1262477
Disease: Weight decreased
Weight decreased
0.400 Therapeutic phenotype CTD_human Alterations in Enterohepatic Fgf15 Signaling and Changes in Bile Acid Composition Depend on Localization of Murine Intestinal Inflammation. 27580383 2016
CUI: C1262477
Disease: Weight decreased
Weight decreased
0.400 Biomarker phenotype CTD_human Alterations in Enterohepatic Fgf15 Signaling and Changes in Bile Acid Composition Depend on Localization of Murine Intestinal Inflammation. 27580383 2016
CUI: C1262477
Disease: Weight decreased
Weight decreased
0.400 Biomarker phenotype HPO
CUI: C0024419
Disease: Waldenstrom Macroglobulinemia
Waldenstrom Macroglobulinemia
0.020 AlteredExpression disease BEFREE Rebound of IL-6 and IL-10 serum levels also accompanied disease progression in WM patients with acquired BTK<sup>Cys481</sup> mutations. 29496671 2018